CD52 and B-cell chronic lymphocytic leukemia: The antibody against CD52 (CAMPATH-1 antigen, a glycoprotein present on the surface of mature lymphocytes and inflamed monocytes and dendritic cells) has been traditionally used for treatment of B cell chronic lymphocytic leukemia.